article thumbnail

The Pharmacy Benefit Management Landscape: A Music Industry Analogy

Drug Patent Watch

"The Prescription for Change: How PBM's are Ripping the Rhythm of the Pharmaceutical Industry Imagine a music industry where a single middleman controlled access to every song, dictating who could play them, when, and at what price. That's essentially the world of Pharmacy Benefit Managers (PBMs) in the pharmaceutical industry.

article thumbnail

India’s Growing Importance in Generic Drug API Manufacturing

Drug Patent Watch

India has long been recognized as a significant player in the global pharmaceutical industry, particularly in the production of generic drugs. The country’s pharmaceutical sector has experienced substantial growth over the years, driven by both domestic and international demand for affordable and high-quality medicines.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Fast Track to Market Dominance: A Strategic Guide to the Patent Prosecution Highway for Expedited Drug Patents

Drug Patent Watch

In pharmaceutical innovation time is not just money; it is the very currency of competitive survival. The journey from a promising molecule in a lab to a life-saving therapy on a pharmacy shelf is a…

article thumbnail

Pharmacognosy and Drug Patents: Unveiling Nature’s Medicinal Treasures

Drug Patent Watch

In the vast realm of pharmaceutical research and development, there’s a fascinating intersection between ancient wisdom and modern science. The Essence of Pharmacognosy: Nature’s Pharmacy Unveiled Imagine walking through a lush rainforest, surrounded by countless plant species. What is a Drug Patent?

article thumbnail

From siloed data to breakthroughs: multimodal AI in drug discovery

Drug Target Review

Multimodal language models Generative AI models (GenAI) in the pharmaceutical field have reached the highest level of attention with the Nobel Prizes to Demis Hassabis and John Jumper for AlphaFold, which can predict protein structures. This approach limits the transformative potential of the technology.

article thumbnail

Novel Pharmaceutical Strategies and Business Models: The Rise of Telehealth Companies Like Ro and Hims & Hers

Drug Patent Watch

"The Telehealth Revolution: How D2C Pharmacies Are Redefining the Industry In a seismic shift, direct-to-consumer (D2C) pharmacies like Ro, Hims, and Hers are upending traditional healthcare business models, leveraging telehealth to deliver convenient, affordable, and personalized care to millions. Read more: [link] "

article thumbnail

New cell therapy model accelerates cancer treatment development

Drug Target Review

In this model, once a product is produced and delivered to the clinical pharmacy, the clinical team takes over the trial with little to no interaction with the manufacturing team. Dr. Bock has previously held leadership roles at MD Anderson, Teva Pharmaceuticals, CoGenesys, and Human Genome Sciences.